Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Nature | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18186149 | 2008 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{cyc:N-C}{ct:Amid} | 6k-f17 | Amidation | Free | Cyclic | D | None | 17 | Antimicrobial | MHC =325μM | Human | Synthetic peptide | random coil | NA | ||
| 18186149 | 2008 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}L{d}L{d}{cyc:N-C}{ct:Amid} | 6k-f17-2l16,17 | Amidation | Free | Cyclic | D | None | 17 | Antimicrobial | MHC <81μM | Human | Synthetic peptide | random coil | NA | ||
| 18779649 | 2008 | G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid} | D-Pleurocidin | Amidation | Free | Linear | D | None | 25 | Antibacterial | 19% hemolysis at 100 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid} | D-Pleurocidin | Amidation | Free | Linear | D | None | 25 | Antibacterial | 0% hemolysis at 3.13-50 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 11478963 | 2001 | L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid} | D-MP-B | Amidation | Free | Linear | D | None | 14 | Hypotensive | 82-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 11478963 | 2001 | L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid} | D-MP-B | Amidation | Free | Linear | D | None | 14 | Hypotensive | 83-85% hemolysis at 15 µM | Guinea-pig | Synthetic peptide | NA | NA | ||
| 21928440 | 2011 | C{d}G{d}E{d}T{d}C{d}V{d}G{d}G{d}T{d}C{d}N{d}T{d}P{d}G{d}C{d}T{d}C{d}S{d}W{d}P{d}V{d}C{d}T{d}R{d}N{d}G{d}L{d}N{d}P{d}V{d}{cyc:N-C} | D-Kalata B1 | Free | Free | Cyclic | D | None | 29 | Anticancer and Anti-HIV | IC50 = 77 µM | Human | Kalata analog (Oldenlandia affinis) | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 2% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{ct:Amid} | All-D F17-6K | Amidation | Free | Linear | D | None | 17 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 10795591 | 2000 | R{d}G{d}G{d}R{d}L{d}C{d}Y{d}C{d}R{d}R{d}R{d}F{d}C{d}V{d}C{d}V{d}G{d}R{d}{ct:Amid} | dPG-1 | Amidation | Free | Linear | D | None | 18 | Antimicrobial | 90% hemolysis at 80µg/ml | Human | PG-1 analog | NA | NA | ||
| 10821683 | 2000 | C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{cyc:N-C} | cyclic-[D]-L3,4,8,10-K4L7W | Free | Free | Cyclic | D | None | 14 | Cytolytic | 90% hemolytic at 50μM | Human | Synthetic peptide | NA | NA | ||
| 10821683 | 2000 | C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{nt:CH3-S-}{ct:-S-CH3} | linear-[D]-L3,4,8,10-K4L7W | Free | Free | Linear | D | None | 14 | Cytolytic | 5% hemolytic at 50μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}W{d}L{d}L{d}A{d}L{d}K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 4.06±1.30μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120-P13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 11.66±0.03μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}W{d}L{d}A{d}L{d}A{d}K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-A | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 17.42±2.17μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}W{d}L{d}P{d}L{d}A{d}K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-AP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 58.61±10.41μMc | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}H{d}A{d}L{d}K{d}K{d}W{d}L{d}H{d}A{d}L{d}K{d}K{d}L{d}A{d}H{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120-H | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 20.29±2.42μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}A{d}H{d}A{d}L{d}K{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}K{d}L{d}A{d}H{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 79.61±2.80μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}A{d}K{d}A{d}L{d}K{d}H{d}W{d}L{d}P{d}A{d}L{d}H{d}K{d}L{d}A{d}K{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK80-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 8.61±0.35μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}K{d}H{d}A{d}L{d}A{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}A{d}L{d}A{d}H{d}K{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK160-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 185.0±18.65μM | Human | Synthetic peptide | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 421.5μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D2 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 83μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D3 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 14μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}L{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D4 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 3.5μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}K{d}L{d}H{d}T{d}L{d}L{d}K{d}L{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D5 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 47μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | L{d}L{d}G{d}D{d}E{d}F{d}R{d}K{d}S{d}K{d}E{d}K{d}I{d}G{d}K{d}E{d}F{d}K{d}R{d}I{d}V{d}Q{d}R{d}I{d}K{d}D{d}F{d}L{d}R{d}N{d}L{d}V{d}P{d}R{d}T{d}E{d}S{d} | D-LL37 | Free | Free | Linear | D | None | 37 | Antimicrobial | HC50 = 125μg/ml | Human | Synthetic peptide | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}V{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 (V13) | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =1.8μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 (K13) | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 140.9μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}V{d}L{d}K{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D11 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 254.1μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D22 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =81.3μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D14 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =351.5μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}L{d}L{d}K{d}T{d}A{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D15 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =169.6μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D16 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =1342.0μM | Human | Synthetic peptides | NA | NA | ||
| 21335383 | 2011 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}K{d}Y{d}L{d}{ct:Amid} | BP153 | Amidation | Free | Linear | D | None | 11 | Antimicrobial | 50±2.1% hemolytic at 250μM | Human | Synthetic peptide of BP100 | NA | NA | ||
| 21343499 | 2011 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid} | HDP D-P18 | Amidation | Free | Linear | D | None | 18 | Antimcrobial and Hemolytic | ~94% hemolytic at 500μM | Human | Host defense peptides analog (Rana temporaria) | NA | NA | ||
| 21343499 | 2011 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid} | HDP D-P18 | Amidation | Free | Linear | D | None | 18 | Antimcrobial and Hemolytic | ~10% hemolytic at 50μM | Human | Host defense peptides analog (Rana temporaria) | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 0% hemolysis upto 80μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 1% hemolysis at 100μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 2% hemolysis at 200μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-HALO-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 =716.8μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid} | D-HALO-P8Frev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 >65.2μM | Human | Synthetic peptide | NA | NA | ||
| 9204560 | 1997 | F{d}R{d}L{d}K{d}F{d}H{d} | 66-10 | Free | Free | Linear | D | None | 6 | Antimicrobial | 0% hemolysis at 312 to 0μg/ml | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 9204560 | 1997 | F{d}R{d}L{d}K{d}F{d}H{d} | 66-10 | Free | Free | Linear | D | None | 6 | Antimicrobial | 0% hemolysis at 312 to 0μg/ml | Bovine | Synthetic Peptide | NA | Non-hemolytic | ||
| 9204560 | 1997 | F{d}R{d}L{d}K{d}F{d}H{d} | 66-10 | Free | Free | Linear | D | None | 6 | Antimicrobial | 0% hemolysis at 312 to 0μg/ml | Ovine | Synthetic Peptide | NA | Non-hemolytic | ||
| 18568863 | 2008 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}V{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | DV681 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | MHC =7.8μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-HALO-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antiparasitic | HC50 =716.8μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid} | D-HALO-P8F-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antiparasitic | HC50 >65.2μM | Human | Synthetic Peptide | NA | NA | ||
| 23925670 | 2013 | F{d}W{d}G{d}A{d}L{d}A{d}K{d}G{d}A{d}L{d}K{d}L{d}I{d}P{d}S{d}L{d}F{d}S{d}S{d}F{d}S{d}K{d}K{d}D{d} | D-Pin2 | Free | Free | Linear | D | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 50 % Hemolysis at 10 µM | Human | African Scorpion Pandinus Imperator | α-Helical | NA | ||
| 24041699 | 2013 | L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | D-CopA3 | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 9 | Antifungal | 0 % Hemolysis at 1.3 µM | Human | Truncated Coprisin Analog Peptide | α-Helical | Non-hemolytic | ||
| 24041699 | 2013 | L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | D-CopA3 | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 9 | Antifungal | 0 % Hemolysis at 2.5 µM | Human | Truncated Coprisin Analog Peptide | α-Helical | Non-hemolytic | ||
| 24041699 | 2013 | L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | D-CopA3 | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 9 | Antifungal | 0 % Hemolysis at 5 µM | Human | Truncated Coprisin Analog Peptide | α-Helical | Non-hemolytic | ||
| 24041699 | 2013 | L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | D-CopA3 | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 9 | Antifungal | 0 % Hemolysis at 10 µM | Human | Truncated Coprisin Analog Peptide | α-Helical | Non-hemolytic | ||
| 24041699 | 2013 | L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | D-CopA3 | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 9 | Antifungal | 0 % Hemolysis at 20 µM | Human | Truncated Coprisin Analog Peptide | α-Helical | Non-hemolytic | ||
| 24041699 | 2013 | L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | D-CopA3 | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 9 | Antifungal | 0 % Hemolysis at 40 µM | Human | Truncated Coprisin Analog Peptide | α-Helical | Non-hemolytic | ||
| 24041699 | 2013 | L{d}L{d}C{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | D-CopA3 | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 9 | Antifungal | 0 % Hemolysis at 80 µM | Human | Truncated Coprisin Analog Peptide | α-Helical | Non-hemolytic | ||
| 24211081 | 2014 | I{d}R{d}I{d}K{d}I{d}R{d}I{d}K{d}{ct:Amid} | IK8-all D | Amidation | Free | Linear | D | None | 8 | Antimicrobial | 10 % Hemolysis at 1750 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}R{d}I{d}K{d}I{d}R{d}{ct:Amid} | IK6-all D | Amidation | Free | Linear | D | None | 6 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}R{d}I{d}K{d}{ct:Amid} | IK4-all D | Amidation | Free | Linear | D | None | 4 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | IR{d}IK{d}IR{d}IK{d}{ct:Amid} | IK8-4D | Amidation | Free | Linear | D | None | 8 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}R{d}V{d}K{d}I{d}R{d}V{d}K{d}I{d}R{d}V{d}K{d}{ct:Amid} | IK12-all D | Amidation | Free | Linear | D | None | 12 | Antimicrobial | 10 % Hemolysis at >125 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24211081 | 2014 | I{d}I{d}R{d}K{d}I{d}I{d}R{d}K{d}{ct:Amid} | Control-all D | Amidation | Free | Linear | D | None | 8 | Antimicrobial | 10 % Hemolysis at >2000 mg/L | Rabbit | Synthetic | β-Sheet | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}V{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 1.8 µM | Human | Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}V{d}K{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 G13K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 7 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}K{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 V12K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 35 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}K{d}V{d}H{d}V{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 I9K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 98 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}L{d}K{d}K{d}V{d}L{d}K{d}A{d}A{d}A{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 0.6 µM | Human | South American Frogs Of The Phyllomedusa | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}K{d}K{d}K{d}V{d}L{d}K{d}A{d}A{d}A{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 L7K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 8.6 µM | Human | Derivative Of D-Dermaseptin S4 | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}K{d}K{d}K{d}V{d}L{d}K{d}A{d}K{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 L7K,A14K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 241 µM | Human | Derivative Of D-Dermaseptin S4 | α-Helix | NA | ||
| 25807936 | 2015 | K{d}{nnr:6#}K{d}{ct:Amid} | P3 | Amidation | Free | Linear | D | 6# = BDZ,benzodiazepine scaffold | 2 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 25807936 | 2015 | K{d}{nnr:6#}F{d}K{d}{ct:Amid} | P8 | Amidation | Free | Linear | D | 6# = BDZ,benzodiazepine scaffold | 3 | Antibacterial | 50 % Hemolysis at >1000 μg/ml | Human | Bdz Peptidomimetic Compounds | α-Helix | NA | ||
| 26574005 | 2016 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid} | BP214 | Amidation | Free | Linear | D | None | 18 | Antimicrobial | 42 % Hemolysis at 150 µM | Human | Bp Analogue | NA | NA | ||
| 26998557 | 2016 | G{d}I{d}M{d}S{d}S{d}L{d}M{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-9 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | G{d}I{d}L{d}S{d}S{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-13 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at 373 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26998557 | 2016 | G{d}I{d}L{d}S{d}S{d}L{d}W{d}K{d}K{d}L{d}K{d}K{d}I{d}I{d}A{d}K{d}{ct:Amid} | HYL-21 | Amidation | Free | Linear | D | None | 16 | Antibacterial, Antifungal | 50 % Hemolysis at >400 µM | Human | Analog Of Hyl | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}P{d}T{d}V{d}L{d}R{d}I{d}I{d}R{d}I{d}A{d}{ct:Amid} | SMAP-29-E1 | Amidation | Free | Linear | D | i = D-Isoleucine | 28 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at 5.5 µM | Human | Smap-29 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}P{d}T{d}V{d}L{d}R{d}{nnr:i}{nnr:i}R{d}{nnr:i}A{d}{ct:Amid} | SMAP-29-E2 | Amidation | Free | Linear | D | i = d-allo-isoleucine | 28 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at 16 µM | Human | Smap-29 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}{ct:Amid} | SMAP-18-E1 | Amidation | Free | Linear | D | i = D-Isoleucine | 18 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at <512 µM | Human | Smap-18 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}{nnr:i}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}{ct:Amid} | SMAP-18-E2 | Amidation | Free | Linear | D | i = d-allo-isoleucine | 18 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at <512 µM | Human | Smap-18 D-Enantiomeric Peptides | α-Helix | NA | ||
| 27900727 | 2016 | I{d}D{d}W{d}K{d}K{d}L{d}L{d}D{d}A{d}A{d}K{d}Q{d}I{d}L{d}{ct:Amid} | D-MPI | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 15 | Antimicrobial | 0.4 % Hemolysis at 256 µM | Human | Polybia-Mpi Analogues | α-Helical | Non-hemolytic | ||
| 28453851 | 2017 | R{d}L{d}W{d}V{d}L{d}W{d}R{d}R{d} | D-Bac8c2,5Leu | Free | Free | Linear | D | None | 8 | Antimicrobial | 50 % Hemolysis at 414 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | F{d}A{d}K{d}L{d}L{d}A{d}K{d}L{d}A{d}K{d}K{d}L{d}L{d} | D-HB43 | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at 77 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | F{d}L{d}G{d}G{d}L{d}I{d}K{d}I{d}V{d}P{d}A{d}M{d}I{d}C{d}A{d}V{d}T{d}K{d}K{d}C{d} | D-Ranalexin | Free | Free | Linear | D | None | 20 | Antimicrobial | 50 % Hemolysis at 195 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | W{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d} | D-WMR3,6Leu | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at >4000 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | K{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d} | DP188Leu | Free | Free | Linear | D | None | 13 | Antimicrobial | 50 % Hemolysis at 873 μg/ml | Human | Synthetic | NA | NA | ||
| 28453851 | 2017 | I{d}L{d}R{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d}K{d} | D-Omiganan | Free | Free | Linear | D | None | 12 | Antimicrobial | 50 % Hemolysis at 1775.5 μg/ml | Human | Synthetic | NA | NA | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.2 % Hemolysis at <20 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.4 % Hemolysis at >30 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | <0.5 % Hemolysis at <70 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 28981608 | 2017 | I{d}L{d}G{d}T{d}I{d}L{d}G{d}L{d}L{d}K{d}S{d}L{d}{ct:Amid} | D-CP | Amidation | Free | Linear | D | lowercase letters correspond to D-amino acids | 12 | Antimicrobial | 0.5 % Hemolysis at 130 µM | Human | D-Counterpart Of Polybia-Cp | Left-hand α-Helical | NA | ||
| 38062792 | 2023 | K{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}L{d} | EB11 | Free | Free | Linear | D | None | 11 | Antimicrobial | MHC at >2000 μg/mL | Human | Peptide−Peptoid Hybrids | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D33 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 89 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}A{d}A{d}K{d}K{d}K{d}K{d}L{d}A{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D34 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 126 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}A{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}A{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D35 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 30 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}A{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}A{d}{nt:Acet}{ct:Amid} | D36 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 61 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}A{d}A{d}A{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D37 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.6 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}A{d}A{d}A{d}K{d}K{d}A{d}L{d}A{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D38 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}A{d}T{d}L{d}S{d}K{d}A{d}A{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}A{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D39 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}A{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}A{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}A{d}{nt:Acet}{ct:Amid} | D40 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 29515090 | 2018 | K{d}F{d}F{d}K{d}K{d}L{d}K{d}N{d}S{d}V{d}K{d}K{d}R{d}A{d}K{d}K{d}F{d}F{d}K{d}K{d}P{d}R{d}V{d}I{d}G{d}V{d}S{d}I{d}P{d}F{d} | analog D-OH-CATH30 | Free | Free | Linear | D | None | 30 | Antimicrobial | ~10 % Hemolysis at 125 µg/mL | Human | Cathelicidin-Derived Peptide From The King Cobra | NA | NA | ||
| 29515090 | 2018 | K{d}F{d}F{d}K{d}K{d}L{d}K{d}N{d}S{d}V{d}K{d}K{d}R{d}A{d}K{d}K{d}F{d}F{d}K{d}K{d}P{d}R{d}V{d}I{d}G{d}V{d}S{d}I{d}P{d}F{d} | analog D-OH-CATH30 | Free | Free | Linear | D | None | 30 | Antimicrobial | 80 % Hemolysis at 250 µg/mL | Human | Analog D-Oh-Cath30 | NA | NA | ||
| 29760411 | 2018 | L-A-L-L-V-R-L-L-V-K-L-(K-K-S-L/I-T-L/I-K-V-L/I-L/I-R-V){cyc:N-C} | Paenialvin-C | Free | Free | Bicyclic | D | None | 23 | Antibacterial | 0 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{ct:Amid} | dCopW | Amidation | Free | Linear | D | None | 9 | Antibacterial | 2.32 ± 0.78 % Hemolysis at 100 µM | Human | Synthetic Copw With D-Amino | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C6:0}{ct:Amid} | dCopW1 | Amidation | Free | Linear | D | C6 = hexanoic acid | 9 | Antibacterial | 0.39 ± 0.66 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C8:0}{ct:Amid} | dCopW2 | Amidation | Free | Linear | D | C8 = Octanoic Acid | 9 | Antibacterial | 0.68 ± 0.47 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C10:0}{ct:Amid} | dCopW3 | Amidation | Free | Linear | D | C10 = decanoic acid | 9 | Antibacterial | 3.66 ± 0.39 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | Non-hemolytic | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C12:0}{ct:Amid} | dCopW4 | Amidation | Free | Linear | D | C12 = Dodecanoic Acid | 9 | Antibacterial | 7.10 ± 0.32 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C14:0}{ct:Amid} | dCopW5 | Amidation | Free | Linear | D | C14 = Tetradecanoic Acid | 9 | Antibacterial | 8.36 ± 0.26 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 30393205 | 2019 | L{d}L{d}W{d}I{d}A{d}L{d}R{d}K{d}K{d}{conj:C16:0}{ct:Amid} | dCopW6 | Amidation | Free | Linear | D | C16 = hexadecanoic acid | 9 | Antibacterial | 11.67 ± 0.55 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 30393205 | 2019 | K{d}{conj:C10:0}K{d}R{d}L{d}A{d}I{d}W{d}L{d}L{d}{ct:Amid} | Retro-dCopW3 | Amidation | Free | Linear | D | C10 = decanoic acid | 9 | Antibacterial | 20.88 ± 1.15 % Hemolysis at 100 µM | Human | Synthetic Copw With Fatty Acid-Conjugated | NA | NA | ||
| 30488526 | 2019 | K{d}K{d}F{d}F{d}R{d}A{d}W{d}W{d}A{d}P{d}R{d}F{d}L{d}K{d}{ct:Amid} | kk14 | Amidation | Free | Linear | D | None | 14 | Antifungal | ~10 % Hemolysis at 200 μg/ml | Sheep | Synthetic Analogues Of Kk14 | aqueous = Random coil, SDS = Random coil | Low hemolytic | ||
| 30848594 | 2019 | K{d}L{d}R{d}S{d}L{d}L{d}R{d}T{d}L{d}S{d}R{d}A{d}K{d}A{d}A{d}K{d}L{d}R{d}T{d}L{d}L{d}R{d}A{d}L{d}S{d}R{d}{nt:Acet}{ct:Amid} | D87(Lys'-6 Arg-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Arg | 26 | Antimicrobial | 50 % Hemolysis at 12 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D84(Lys¹-6 Lys-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Lys | 26 | Antimicrobial | 50 % Hemolysis at 155.5 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:o}S{d}L{d}L{d}{nnr:o}T{d}L{d}S{d}{nnr:o}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:o}T{d}L{d}L{d}{nnr:o}A{d}L{d}S{d}{nnr:o} | D85(Lys'-6 Orn-1) | Amidation | Acetylation | Linear | D | o = D-Ornithine | 26 | Antimicrobial | 50 % Hemolysis at 406.5 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}S{d}{nt:Acet}{ct:Amid} | D101(Lys' Ser26-5 Lys-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Lys | 26 | Antimicrobial | 50 % Hemolysis at 279 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:o}S{d}L{d}L{d}{nnr:o}T{d}L{d}S{d}{nnr:o}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:o}T{d}L{d}L{d}{nnr:o}A{d}L{d}S{d}{nnr:o} | D85(K13A/K16A) -(Lys'-6 Orn-1) | Amidation | Acetylation | Linear | D | o = D-Ornithine | 26 | Antimicrobial | 50 % Hemolysis at 2.3 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 31159194 | 2019 | R{d}R{d}Q{d}R{d}R{d}K{d}K{d}R{d}G{d}Y{d}G{d}Y{d}W{d}G{d}D{d}I{d}M{d}G{d}E{d}W{d}G{d}N{d}E{d}I{d}F{d}G{d}E{d}I{d}A{d}E{d}F{d}L{d}G{d}C{d} | 38d | Free | Free | Linear | D | None | 34 | NA | 50 % Hemolysis at 5 µM (pH 5.5) | Human | Chimeric Peptide | NA | NA | ||
| 31159194 | 2019 | C{d}R{d}R{d}Q{d}R{d}R{d}K{d}K{d}R{d}G{d}Y{d}G{d}Y{d}W{d}G{d}D{d}I{d}M{d}G{d}E{d}W{d}G{d}N{d}E{d}I{d}F{d}G{d}E{d}I{d}A{d}E{d}F{d}L{d}G{d} | 38e | Free | Free | Linear | D | None | 34 | NA | 50 % Hemolysis at 0.1 µM (pH 5.5) | Human | Chimeric Peptide | NA | NA | ||
| 31159194 | 2019 | C{d}G{d}L{d}F{d}E{d}A{d}I{d}E{d}G{d}F{d}I{d}E{d}N{d}G{d}W{d}E{d}G{d}M{d}I{d}D{d}G{d}W{d}Y{d}G{d}Y{d}G{d}R{d}K{d}K{d}R{d}R{d}Q{d}R{d}R{d} | 38f | Free | Free | Linear | D | None | 34 | NA | 50 % Hemolysis at 2.3 µM (pH 5.5) | Human | Chimeric Peptide | NA | NA | ||
| 31159194 | 2019 | R{d}R{d}Q{d}R{d}R{d}K{d}K{d}R{d}G{d}Y{d}G{d}Y{d}W{d}G{d}D{d}I{d}M{d}G{d}E{d}W{d}G{d}N{d}E{d}I{d}F{d}G{d}E{d}I{d}A{d}E{d}F{d}L{d}G{d}C{d} | 38d | Free | Free | Linear | D | None | 34 | NA | 50 % Hemolysis at >100 µM (pH 7.4) | Human | Chimeric Peptide | NA | NA | ||
| 31159194 | 2019 | C{d}R{d}R{d}Q{d}R{d}R{d}K{d}K{d}R{d}G{d}Y{d}G{d}Y{d}W{d}G{d}D{d}I{d}M{d}G{d}E{d}W{d}G{d}N{d}E{d}I{d}F{d}G{d}E{d}I{d}A{d}E{d}F{d}L{d}G{d} | 38e | Free | Free | Linear | D | None | 34 | NA | 50 % Hemolysis at 1.51 µM (pH 7.4) | Human | Chimeric Peptide | NA | NA | ||
| 31159194 | 2019 | C{d}G{d}L{d}F{d}E{d}A{d}I{d}E{d}G{d}F{d}I{d}E{d}N{d}G{d}W{d}E{d}G{d}M{d}I{d}D{d}G{d}W{d}Y{d}G{d}Y{d}G{d}R{d}K{d}K{d}R{d}R{d}Q{d}R{d}R{d} | 38f | Free | Free | Linear | D | None | 34 | NA | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Chimeric Peptide | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 23 % Hemolysis at 150 µM | Human | Synthetic All D-Peptide Analogue Peptide | TFE = α-Helical | NA | ||
| 31847173 | 2019 | A{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-1 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 41 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}A{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-2 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 59 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}A{d}F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-3 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 2 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | Low hemolytic | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})A{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-4 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 22 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}A{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-5 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 47 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}A{d}K{d}({nnr:nle}){ct:Amid} | D2D analog-6 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 10 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})A{d}({nnr:nle}){ct:Amid} | D2D analog-7 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 67 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}A{d}{ct:Amid} | D2D analog-8 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 5 % Hemolysis at 150 µM | Human | D2D Analogues | α-Helical | Low hemolytic | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}({nnr:1-nal})({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-9 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 20 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}({nnr:dap})({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-10 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, dap = Diaminopropionic acid, D-amino acid | 8 | Antimicrobial | 28 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}({nnr:nle})({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-11 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 33 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}F{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-12 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 74 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}S{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-13 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 29 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}T{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-14 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 28 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}Y{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-15 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 40 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}V{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-16 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 54 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})({nnr:1-nal})({nnr:nle}){ct:Amid} | D2D analog-17 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 89 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})({nnr:dap})({nnr:nle}){ct:Amid} | D2D analog-18 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, dap = Diaminopropionic acid, D-amino acid | 8 | Antimicrobial | 21 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})({nnr:nle})({nnr:nle}){ct:Amid} | D2D analog-19 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 56 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})F{d}({nnr:nle}){ct:Amid} | D2D analog-20 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 91 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})S{d}({nnr:nle}){ct:Amid} | D2D analog-21 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 85 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})T{d}({nnr:nle}){ct:Amid} | D2D analog-22 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 66 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})Y{d}({nnr:nle}){ct:Amid} | D2D analog-23 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 74 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})V{d}({nnr:nle}){ct:Amid} | D2D analog-24 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}K{d}({nnr:1-nal})({nnr:nle}){ct:Amid} | D2D analog-25 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})({nnr:nle})K{d}{ct:Amid} | D2D analog-26 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 18 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-27 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 7 | Antimicrobial | 49 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | ({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-28 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 6 | Antimicrobial | 62 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-29 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 5 | Antimicrobial | 12 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}{ct:Amid} | D2D analog-30 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, D-amino acid | 7 | Antimicrobial | 11 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal}){ct:Amid} | D2D analog-31 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, D-amino acid | 6 | Antimicrobial | 20 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}{ct:Amid} | D2D analog-32 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, D-amino acid | 5 | Antimicrobial | 5 % Hemolysis at 150 µM | Human | D2D Analogues | NA | Low hemolytic | ||
| 31847173 | 2019 | R{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-33 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 60 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}R{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-34 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 35 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}R{d}({nnr:1-nal})K{d}({nnr:nle}){ct:Amid} | D2D analog-35 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 49 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 31847173 | 2019 | K{d}K{d}({nnr:1-nal})F{d}K{d}({nnr:1-nal})R{d}({nnr:nle}){ct:Amid} | D2D analog-36 | Amidation | Free | Linear | D | 1-nal = D-1-naphthylalanine, nle = D-Norleucine, D-amino acid | 8 | Antimicrobial | 51 % Hemolysis at 150 µM | Human | D2D Analogues | NA | NA | ||
| 32003561 | 2020 | K{d}W{d}C{d}F{d}R{d}V{d}C{d}Y{d}R{d}G{d}L{d}C{d}Y{d}R{d}R{d}C{d}R{d}X{d} | TPAD | Free | Free | Linear | D | None | 18 | Antibacterial | 10 % Hemolysis at 16 μg/mL | Human | D-Amino Acid Analogue Of Tpi | β-Hairpin | NA | ||
| 32590058 | 2020 | G{d}F{d}G{d}S{d}L{d}L{d}G{d}K{d}A{d}L{d}R{d}L{d}G{d}A{d}N{d}V{d}L{d}{ct:Amid} | DCPF-C1 | Amidation | Free | Linear | D | None | 17 | Antibacterial | ≥10 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical (reverse Helical) | NA | ||
| 32590058 | 2020 | GFGSLLGKALRLWKKVL{ct:Amid} | CPF-13 | Amidation | Free | Linear | D | None | 17 | Antibacterial | ≥75 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = α-Helical | NA | ||
| 32786271 | 2020 | K{d}ffK{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid} | HC1-D2 | Amidation | Free | Linear | D | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 31 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = α-Helix | NA | ||
| 32786271 | 2020 | K{d}ffK{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid} | HC1-D2 | Amidation | Free | Linear | D | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 12 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = α-Helix | NA | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 10 % Hemolysis at 1200 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 0 % Hemolysis at 500 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33398076 | 2021 | R{d}I{d}V{d}Q{d}R{d}I{d}K{d}K{d}W{d}L{d}R{d}{ct:Amid} | D-11 | Amidation | Free | Linear | D | None | 11 | Antibacterial | 0 % Hemolysis at 600 μM | Human | Subsitituted With D Amino Acid In L-11 (Synthetic Peptides ) | NA | Non-hemolytic | ||
| 33532575 | 2021 | K{d}Y{d}K{d}K{d}A{d}L{d}K{d}K{d}L{d}A{d}K{d}L{d}L{d} | D-SB1 | Free | Free | Linear | D | None | 13 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | V{d}Q{d}W{d}R{d}A{d}I{d}R{d}V{d}R{d}V{d}I{d}R{d} | D-DJK5 | Free | Free | Linear | D | None | 12 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | I{d}L{d}P{d}W{d}K{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d} | D-Indo | Free | Free | Linear | D | None | 13 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d} | D-G3KL | Free | Free | Branched | D | None | 37 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | O{d}F{d}O{d}F{d}O{d}F{d}O{d}F{d}K{d}B{d}L{d}K{d}B{d}L{d}K{d}K{d}L{d}K{d}{ct:C10} | D-TNS18 | Free | Free | Branched | D | None | 18 | Antibacterial. Antibiofilm | MHC at 500 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Low hemolytic | ||
| 33532575 | 2021 | K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d} | D-T25 | Free | Free | Branched | D | None | 38 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 33890759 | 2021 | K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}{nt:C10}{ct:Amid} | C10-KR8d | Amidation | C10 | Linear | D | None | 8 | Antibacterial | 50 % Hemolysis at 300 μM | Human | Synthetic Peptide | NA | Low hemolytic | ||
| 33890759 | 2021 | K{d}R{d}I{d}W{d}Q{d}R{d}I{d}K{d}D{d}F{d}{nt:C8}{ct:Amid} | C8-KR10d | Amidation | C8 | Linear | D | None | 10 | Antibacterial | 50 % Hemolysis at 150 μM | Human | Synthetic Peptide | NA | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 33.26 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.4 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.5 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.9 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 2.5 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 8.7 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 23.6 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 65.6 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 35.1 ± 8.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 64.4 ± 9.4 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 71.0 ± 7.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 1.94 ± 0.94 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 2.75 ± 0.23 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 30.39 ± 2.11 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | R{d}R{d}L{d}F{d}R{d}R{d}I{d}L{d}R{d}W{d}L{d}{ct:Amid} | RW-BP100-All-D | Amidation | Free | Linear | D | None | 11 | Antibacterial | 51.40 ± 1.94 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 36551443 | 2022 | G{d}R{d}R{d}R{d}R{d}S{d}V{d}Q{d}W{d}C{d}A{d} | hLF 1-11(D-form) | Free | Free | Linear | D | None | 11 | Antimycobacterial | <1 % Hemolysis at 4000 µg/mL | Human | Homo Sapiens | NA | Non-hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid} | D-W3R6 | Amidation | Free | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Analog Of W3R6 | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid} | D-Arg-W3R6 | Amidation | Free | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Diastereomer Of W3R6 | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:Acetylation(CH3COOH)}{ct:Amid} | AC-D-W3R6 | Amidation | Acetylation(CH3COOH) | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of D-W3R6 (Acetyl) | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:butanoyl = CH3(CH2)2COOH}{ct:Amid} | BA-D-W3R6 | Amidation | butanoyl = CH3(CH2)2COOH | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at >500 µM | Human | Lipidated Analog Of D-W3R6 (Butanoyl) | NA | Low hemolytic | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:octanoyl = C8H16O2}{ct:Amid} | OA-D-W3R6 | Amidation | octanoyl = C8H16O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 100 µM | Human | Lipidated Analog Of D-W3R6 (Octanoyl) | NA | NA | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:lauric acyl = C12H24O2}{ct:Amid} | LA-D-W3R6 | Amidation | lauric acyl = C12H24O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 25 µM | Human | Lipidated Analog Of D-W3R6 (Lauric Acid) | NA | NA | ||
| 37336295 | 2023 | V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:palmitic acyl = C16H32O2}{ct:Amid} | PA-D-W3R6 | Amidation | palmitic acyl = C16H32O2 | Linear | D | None | 11 | Antimycobacterial | 50 % Hemolysis at 25 µM | Human | Lipidated Analog Of D-W3R6 (Palmitic Acid) | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{ct:Amid} | BP214 | Amidation | Free | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 41 % Hemolysis at 150 μM | Human | Synthetic | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C4)}{ct:Amid} | 1 | Amidation | lipidated (C4) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp214 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C6)}{ct:Amid} | 2 | Amidation | lipidated (C6) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp215 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C8)}{ct:Amid} | 3 | Amidation | lipidated (C8) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp216 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C10)}{ct:Amid} | 4 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp217 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C12)}{ct:Amid} | 5 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp218 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}L{d}{nt:lipidated (C14)}{ct:Amid} | 6 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp219 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 7 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp220 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 8 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp221 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{ct:Amid} | 9 | Amidation | Free | Linear | D | Lower-case letters signify D-amino acids | 11 | Antimicrobial | 3 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp222 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 10 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 81 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp223 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 11 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 96 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp224 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 12 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 95 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp225 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 13 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 36 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp226 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 14 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 98 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp227 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 15 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 83 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp228 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C10)}{ct:Amid} | 16 | Amidation | lipidated (C10) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 59 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp229 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C12)}{ct:Amid} | 17 | Amidation | lipidated (C12) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 100 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp230 | NA | NA | ||
| 36009951 | 2022 | K{d}K{d}L{d}F{d}K{d}K{d}I{d}L{d}R{d}Y{d}K{d}{nt:lipidated (C14)}{ct:Amid} | 18 | Amidation | lipidated (C14) | Linear | D | C= lipidated; Lower-case letters signify D-amino acids | 11 | Antimicrobial | 94 % Hemolysis at 150 μM | Human | Synthetic; C-Locked Analog Of Bp231 | NA | NA | ||
| 35812346 | 2022 | R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}{nt:H}{ct:OH} | R18D (acetate) | OH | H | Linear | D | Lower case r = d-arginine | 18 | Mast cell degranulation inducer | No Hemolysis at 16 μM | Human | Synthetic | NA | Non-hemolytic | ||
| 36297519 | 2022 | K{d}K{d}I{d}R{d}V{d}R{d}L{d}S{d}A{d} | M33D | Free | Free | Linear | D | None | 9 | Antimicrobial | NA | Human | Synthetic | NA | Non-hemolytic | ||
| 36297519 | 2022 | K{d}K{d}L{d}R{d}V{d}R{d}L{d}S{d}A{d} | M33i/l | Free | Free | Linear | D | None | 9 | Antimicrobial | NA | Human | Synthetic | NA | Non-hemolytic | ||
| 10931184 | 2000 | G{d}I{d}L{d}D{d}T{d}I{d}K{d}S{d}I{d}A{d}S{d}K{d}V{d}W{d}N{d}S{d}K{d}T{d}V{d}Q{d}D{d}L{d}K{d}R{d}K{d}G{d}I{d}N{d}W{d}V{d}A{d}N{d}K{d}L{d}G{d}V{d}S{d}P{d}Q{d}A{d}A{d} | D-isomer Hadrurin | Free | Free | Linear | D | None | 41 | Antibacterial, hemolytic | 100 % Hemolysis at 5μM | Human | Venom, Hadrurus Aztecus, Mexico, North America | NA | NA | ||
| 31209048 | 2019 | G{d}L{d}S{d}L{d}L{d}L{d}S{d}L{d}G{d}L{d}K{d}L{d}L{d}{ct:Amid} | DFT503d | Amidation | Free | Linear | D | None | 13 | Antibacterial, Anti-MRSA, Hemolytic | HL50 % Hemolysis at >300µM | Human | Synthetic Peptide | NA | NA |